BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 229130)

  • 1. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
    Heald J; Buckley CH; Fox H
    J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.
    Khoo SK; MacKay EV
    Br J Obstet Gynaecol; 1976 Oct; 83(10):753-9. PubMed ID: 990213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and immunohistochemical studies on carcinoembryonic antigen of ovarian mucinous and serous tumors.
    Tohya T; Iwamasa T; Maeyama M
    Gynecol Oncol; 1986 Mar; 23(3):291-303. PubMed ID: 3514390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
    Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
    Melnick H; Barber HR
    Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistochemical localisation of carcinoembryonic antigen (CEA) in malignant epithelial ovarian tumours using monoclonal antibodies.
    Gogate N; Deshmukh S
    Indian J Pathol Microbiol; 1995 Apr; 38(2):199-201. PubMed ID: 8919110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An immunohistochemical study of intestinal mucinous antigens and CEA in ovarian epithelial tumors].
    Liu A; Wang M; Li H
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):366-8. PubMed ID: 8732094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T; Maruo T; Iwasaki M; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
    Macdonald F; Bird R; Stokes H; Russell B; Crocker J
    J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
    Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
    Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical studies on carcinoembryonic antigen in adenocarcinomas of the uterus.
    Ueda S; Tsubura A; Izumi H; Sasaki M; Morii S
    Acta Pathol Jpn; 1983 Jan; 33(1):59-69. PubMed ID: 6340419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
    Kataoka A; Yakushiji M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies.
    Charpin C; Bhan AK; Zurawski VR; Scully RE
    Int J Gynecol Pathol; 1982; 1(3):231-45. PubMed ID: 6193072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms.
    van Nagell JR; Pletsch QA; Goldenberg DM
    Cancer Res; 1975 Jun; 35(6):1433-7. PubMed ID: 805659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
    Kato T; Nishimura H; Hamai J; Yamabe T; Nakajima H; Nakano T; Noda K; Teshima K; Suzuki H; Ueda G
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2338-45. PubMed ID: 3007640
    [No Abstract]   [Full Text] [Related]  

  • 20. Intestine-associated antigens in ovarian tumours: an immunohistological study.
    De Boer WG; Ma J; Nayman J
    Pathology; 1981 Jul; 13(3):547-55. PubMed ID: 7029434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.